Pharming « Terug naar discussie overzicht

Pharming januari 2018

11.235 Posts, Pagina: « 1 2 3 4 5 6 ... 380 381 382 383 384 385 386 387 388 389 390 ... 558 559 560 561 562 » | Laatste
[verwijderd]
0
Is dat de noorse variant van het US bedrijf?
Wel de hele info plaatsen ajb....
Je bericht gaat enkel over Q4

+++++++++++++++++++

Johnson & Johnson beats by $0.02, beats on revenue
Jan. 23, 2018 6:42 AM ET|About: Johnson & Johnson (JNJ)|By: Mamta Mayani, SA News Editor

Johnson & Johnson (NYSE:JNJ): Q4 EPS of $1.74 beats by $0.02.

Revenue of $20.2B (+11.5% Y/Y) beats by $130M.

Shares +0.27% PM.

Net loss and diluted loss per share for the fourth quarter of 2017 were $10.7 billion and $3.99, respectively. Fourth-quarter 2017 net loss included after-tax intangible amortization expense of approximately $0.9 billion and a net charge for after-tax special items of approximately $14.6 billion. Included in these special items is a provisional amount of approximately $13.6 billion associated with the recent enactment of tax legislation.** Fourth-quarter 2016 net earnings included after-tax intangible amortization expense of approximately $0.3 billion and a net charge for after-tax special items of approximately $0.3 billion. Excluding after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $4.8 billion and adjusted diluted earnings per share were $1.74, representing increases of 9.5% and 10.1%, respectively, as compared to the same period in 2016.* On an operational basis, adjusted diluted earnings per share increased 5.7%.* A reconciliation of non-GAAP financial measures is included as an accompanying schedule.

seekingalpha.com/pr/17053129-johnson-...

Net loss and diluted loss per share for the fourth quarter of 2017 were $10.7 billion and $3.99, respectively. Fourth-quarter 2017 net loss included after-tax intangible amortization expense of approximately $0.9 billion and a net charge for after-tax special items of approximately $14.6 billion. Included in these special items is a provisional amount of approximately $13.6 billion associated with the recent enactment of tax legislation.** Fourth-quarter 2016 net earnings included after-tax intangible amortization expense of approximately $0.3 billion and a net charge for after-tax special items of approximately $0.3 billion. Excluding after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $4.8 billion and adjusted diluted earnings per share were $1.74, representing increases of 9.5% and 10.1%, respectively, as compared to the same period in 2016.* On an operational basis, adjusted diluted earnings per share increased 5.7%.* A reconciliation of non-GAAP financial measures is included as an accompanying schedule.
Net earnings and diluted earnings per share for the full-year 2017 were $1.3 billion and $0.47, respectively.
[verwijderd]
0
quote:

Teddieke schreef op 23 januari 2018 12:38:

[...]

Daar zou ik graag in investeren maar ik kan geen broker vinden waar ik in HMMJ kan handelen.
DeGiro kon het, maar daar is de handel in die ETF geschorst omwille van nieuwe regelgeving.

Ik wacht met smart totdat dit weer mogelijk is.
tralalala
0
quote:

Theo3 schreef op 23 januari 2018 12:19:

Auroa cannabis Dt. Cannabis ago.n Weedmd.inc
Heb jij Weedmd realtime?
Zo nee doe jij het op gevoel, uhh ik bedoel aandeeltjes handelen ;-)
NEVDK
0
quote:

Groentje55 schreef op 23 januari 2018 12:25:

[...]kan dat via ing???
oppassen is al x7 gegaan .... meer of minder zeg ik niet..
nescio
0
quote:

Deneus schreef op 23 januari 2018 12:50:

lijkt wel een koffieshop hier met al die cannabis lol.
"C" coffeeshop. Neus
[verwijderd]
0
quote:

geldding2 schreef op 23 januari 2018 12:35:

[...]

Portefeuilleoverzicht 23-01-2018 12:30:01Bijgewerkt tot:
CPT
Vermogen Portefeuille Kas Bestedingsruimte
€ 592.009,25 € 591.199,20 € 810,05

Ongerealiseerd resultaat Totaal
?
38,69% € 164.933,28

Portefeuilleoverzicht 23-01-sint juttemis 11:11:11Bijgewerkt tot:
CPT
Vermogen Portefeuille Kas Bestedingsruimte
€ 1.592.009,20 €1.111.111,11 € 480.898.09

Ongerealiseerd resultaat Totaal
?
1.111,11% €151.151.151,51

O shit! did I mention it is a papertrading account?
[verwijderd]
0
[Modbreak IEX: Gelieve elkaar niet persoonlijk aan te vallen, bericht is bij dezen verwijderd.]
RW1963
0
quote:

Theo3 schreef op 23 januari 2018 12:20:

Aurora is de beste op dit moment
Heb ik ook
niccienieuw
0
quote:

NEVDK schreef op 23 januari 2018 13:04:

[...]

oppassen is al x7 gegaan .... meer of minder zeg ik niet..
Ik hoop dat je het niet erg vind, maar ik ben nog zo'n leek en wil dan toch graag doorvragen. Hoop dat je antwoordt. Verwacht je zoiets als bij probiodrug? Prijs opstuwen en dan groot aandeelhouders ineens eruit?
[verwijderd]
0
quote:

Deneus schreef op 23 januari 2018 12:50:

lijkt wel een koffieshop hier met al die cannabis lol.
Steek er nog maar eentje op.
[verwijderd]
0
quote:

twopence schreef op 23 januari 2018 13:23:

Nou,nou, Pharming in het rood. Als dat maar goed gaat.
De late lunch dip.........
torro
0
quote:

twopence schreef op 23 januari 2018 13:23:

Nou,nou, Pharming in het rood. Als dat maar goed gaat.
buy on the ......
11.235 Posts, Pagina: « 1 2 3 4 5 6 ... 380 381 382 383 384 385 386 387 388 389 390 ... 558 559 560 561 562 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 25 apr 2024 17:15
Koers 0,885
Verschil -0,020 (-2,16%)
Hoog 0,910
Laag 0,875
Volume 3.482.302
Volume gemiddeld 6.865.849
Volume gisteren 6.519.524

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront